Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-20 · accession 0001209191-24-003708 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-02-21	2024-02-20	RXRX	Borgeson Blake	Dir	S - Sale	$12.32	-20.1K	7.29M	-0.3%	-$247.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-02-20	S	D	309	$13.04	7,292,863	D	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.98 to $13.08 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2024-02-20	S	D	19,745	$12.31	7,293,172	D	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.97 to $12.96 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.